Skip to main content
Download PDF

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program

BMC Cancer volume 16, Article number: 518 (2016) Cite this article

The Original Article was published on 07 July 2016

Erratum

After publication of the original article [1], an error was noticed within the title: acronym “REBECCA” was erroneously written as “REBACCA”. The original article has now been updated with the correct title which can also be found above. The publisher would like to apologise for this error and for any inconvenience this may have caused.

References

  1. Adenis A, de la Fouchardiere C, Paule B, Burtin P, Tougeron D, Wallet J, et al. Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program. BMC Cancer. 2016;16:412. doi:10.1186/s12885-016-2440-9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Oncology, Centre Oscar Lambret and Catholic University, Lille, France

    Antoine Adenis

  2. Medical Oncology, Centre Léon Bérard, Lyon, France

    Christelle de la Fouchardiere

  3. Medical Oncology, Paul Brousse University Hospital, Villejuif, France

    Bernard Paule

  4. Medical Oncology, Gustave Roussy, Villejuif, France

    Pascal Burtin

  5. Gastroenterology, University Hospital, Poitiers, France

    David Tougeron

  6. Methodology and Biostatistics, Centre Oscar Lambret, Lille, France

    Jennifer Wallet & Andrew Kramar

  7. Medical Oncology, Clinique Sainte Anne, Strasbourg, France

    Louis-Marie Dourthe

  8. Medical Oncology, Hopital Privé des Côtes d’Armor, Plérin, France

    Pierre-Luc Etienne

  9. Radiation and Medical Oncology, Institut Sainte-Catherine, Avignon, France

    Laurent Mineur

  10. Clinical Research Unit, Centre Oscar Lambret, Lille, France

    Stéphanie Clisant

  11. Gastroenterology, University Hospital, Saint Etienne, France

    Jean-Marc Phelip

  12. Medical Oncology, Saint Antoine Hospital, and University Pierre et Marie Curie (UMPC), Paris VI, Paris, France

    Thierry Andre

  13. Department of Medical Oncology, Centre Oscar Lambret, 3, rue F Combemale, 59000, Lille, France

    Antoine Adenis

Authors
  1. Antoine Adenis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christelle de la Fouchardiere
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernard Paule
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pascal Burtin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David Tougeron
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jennifer Wallet
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Louis-Marie Dourthe
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pierre-Luc Etienne
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Laurent Mineur
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Stéphanie Clisant
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jean-Marc Phelip
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Andrew Kramar
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Thierry Andre
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antoine Adenis.

Additional information

The online version of the original article can be found under doi:10.1186/s12885-016-2440-9.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adenis, A., de la Fouchardiere, C., Paule, B. et al. Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program. BMC Cancer 16, 518 (2016). https://doi.org/10.1186/s12885-016-2559-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-016-2559-8

BMC Cancer

ISSN: 1471-2407

Contact us